A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

840

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 26, 2024

Study Completion Date

August 31, 2025

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL

MCV4

1 dose of MCV4 on Day 0

BIOLOGICAL

MPSV4

1 dose of MSPV4 on Day 0

Trial Locations (3)

Jiangjin District Center for Disease Control and Prevention, Chongqing

Wanzhou District Center for Disease Control and Prevention, Chongqing

Yuzhong District Center for Disease Control and Prevention, Chongqing